HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.

AbstractBACKGROUND:
Leucine zipper/EF hand-containing transmembrane-1 (LETM1) is a mitochondrial inner membrane protein that was first identified in Wolf-Hirschhorn syndrome. However, high-level expression of LETM1 has been correlated with multiple human malignancies, suggesting roles in carcinogenesis and tumor progression. This study is aimed to explore the clinicopathological characteristics and prognostic value of LETM1 overexpression in breast cancer.
METHODS:
Immunohistochemical (IHC) staining, and immunofluorescence (IF) were performed to examine LETM1 expression in breast cancer cell line/tissues compared with adjacent normal tissues. Statistical analysis was applied to evaluate the correlation between LETM1 overexpression and the clinicopathological features of breast cancer. Survival rates were calculated using the Kaplan-Meier method, and the relationship between prognostic factors and patient survival was analyzed using the Cox proportional hazard models.
RESULTS:
LETM1 protein showed cytoplasmic staining pattern in breast cancer. The strongly positive rate of LETM1 protein was 61.6% (98/159) in breast cancer, which was significantly higher than in DCIS (29.7%, 11/37), hyperplasia (16.7%, 3/18) and adjacent normal breast tissues (15.9%, 7/44). High-level expression of LETM1 protein was correlated with lymph node metastasis, poor differentiation, late clinical stage, disease-free survival (DFS) and overall survival (OS) rates in breast cancer. Moreover, multivariate analysis suggested that LETM1 emerged as a significant independent prognostic factor along with clinical stage of patients with breast cancer.
CONCLUSIONS:
LETM1 plays an important role in the progression of breast cancer. High level expression of LETM1 is an independent poor prognostic factor of breast cancer.
AuthorsNan Li, Yahui Zheng, Chouhui Xuan, Zhenhua Lin, Longzhen Piao, Shuangping Liu
JournalInternational journal of clinical and experimental pathology (Int J Clin Exp Pathol) Vol. 8 Issue 10 Pg. 12893-900 ( 2015) ISSN: 1936-2625 [Electronic] United States
PMID26722481 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Calcium-Binding Proteins
  • LETM1 protein, human
  • Membrane Proteins
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms (metabolism, mortality, pathology)
  • Calcium-Binding Proteins (analysis, biosynthesis)
  • Carcinoma, Ductal, Breast (metabolism, mortality, pathology)
  • Carcinoma, Intraductal, Noninfiltrating (metabolism, mortality, pathology)
  • Disease Progression
  • Disease-Free Survival
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Kaplan-Meier Estimate
  • Membrane Proteins (analysis, biosynthesis)
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: